Lopez-Sendon J, Swedberg K, McMurray J et al. Expert consensus document on β-adrenergic receptor blockers. Eur. Heart. J. 25(15), 1341–1362 (2004). Brodde OE. β-1 and β-2 adrenoceptor ...

The clinical benefit of β blockade has been proven in a variety of pathologic settings, including hypertension, angina pectoris, acute- and post-myocardial infarction, and congestive heart failure.

Beta-blockers can treat a variety of conditions including diabetes. They might cause certain side effects such as headaches and fatigue. People with diabetes tend to develop heart disease or ...

1Children’s Research Institute and the Department of Pediatrics, University of Texas Southwestern Medical Center, Dallas, Texas. 10Howard Hughes Medical Institute, UT Southwestern Medical Center, ...

Beta blockers are typically used to manage abnormal heart rhythms, reduce high blood pressure, or treat angina (chest pain). They work by blocking the body's beta receptors, which are stimulated ...

Objective To examine the effect of concomitant intake of β blockers with angiotensin converting enzyme (ACE) inhibitors, diuretics, or both on plasma renin concentrations in a population based sample ...

Inhibitors of the renin–angiotensin–aldosterone (RAAS) system are cornerstones of the management of patients with heart failure with reduced left ventricular ejection fraction (HFrEF). However, RAAS ...

This study presents a valuable finding on the role of cholesterol-binding site on GLP-1 receptors and functionally characterizes the impact of this mutation on receptor behavior in the membrane and ...

Many individual lipids, such as the serum cholesterol, phospholipid and various beta-lipoprotein fractions, have been extensively evaluated as indicators of coronary heart disease. Attempts have ...